Table 2. AUC, sensitivity, specificity, PPV and NPV of IgA-gH/gL, IgA-VCA, EBV DNA and their combinations for detection of NPC in the training cohort.
| Test | AUC (95%) | pa | Sensitivity | pb | Specificity | pb | PPV | pc | NPV | pc | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |||||||
| gH/gL | 0.893 (0.862-0.924) | 83.7 | 78.7-88.7 | 82.3 | 77.0-87.6 | 83.3 | 78.2-88.4 | 82.7 | 77.4-88.0 | |||||
| VCA | 0.933 (0.906-0.959) | 84.6 | 79.7-89.5 | 93.4 | 89.9-96.9 | 93.1 | 89.5-96.7 | 85.3 | 80.6-90.0 | |||||
| EBV DNA | 0.849 (0.810-0.889) | 71.6 | 65.5-77.7 | 94.9 | 91.8-98.0 | 93.7 | 89.9-97.5 | 76.1 | 70.8-81.4 | |||||
| gH/gL vs. VCA | NS | NS | 0.002 | 0.003 | NS | |||||||||
| gH/gL vs. EBVDNA | 0.046 | 0.004 | <0.001 | 0.002 | NS | |||||||||
| VCA vs. EBVDNA | <0.001 | 0.001 | NS | NS | 0.013 | |||||||||
| gH/gL + VCA | 0.980 (0.970-0.991) | 88.5 | 84.2-92.8 | 97.0 | 94.6-99.4 | 96.8 | 94.3-99.3 | 88.9 | 84.7-93.1 | |||||
| gH/gL + EBV DNA | 0.941 (0.919-0.963) | 87.5 | 83.0-92.0 | 89.4 | 85.1-93.7 | 89.7 | 83.5-93.9 | 87.2 | 82.6-91.8 | |||||
| VCA + EBV DNA | 0.967 (0.949-0.985) | 87.5 | 83.0-92.0 | 97.4 | 95.2-99.6 | 97.3 | 95.0-99.6 | 88.1 | 83.8-92.4 | |||||
| gH/gL vs.gH/gL + VCA | <0.001 | NS | <0.001 | <0.001 | NS | |||||||||
| VCA vs.gH/gL + VCA | <0.001 | 0.039 | NS | NS | NS | |||||||||
| EBV DNA vs.gH/gL + VCA | <0.001 | <0.001 | NS | NS | <0.001 | |||||||||
| gH/gL + VCA vs. gH/gL + EBV DNA | <0.001 | NS | 0.001 | 0.005 | NS | |||||||||
| gH/gL + VCA vs. VCA + EBV DNA | NS | NS | NS | NS | NS | |||||||||
PPV, positive predictive value; NPV, negative predictive value; NS, not significant; gH/gL, enzyme-linked immunosorbent assay detection of IgA antibodies against EBV glycoprotein complex gH/gL; VCA, immunofluorescence assay for IgA antibodies against viral capsid antigen; EBV DNA, qPCR test for plasma circulating EBV DNA.
Z test.
McNemar's paired-sample test.
Chi-squared test.